Coupled Inspiratory and Expiratory Muscle Training in Children With Bronchial Asthma

NCT ID: NCT05212558

Last Updated: 2022-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-02

Study Completion Date

2021-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed to assess the effect of inspiratory and expiratory muscle training in the same cycle on respiratory muscle strength, pulmonary functions, perception of asthma symptoms in children with bronchial asthma. Fifty-one children with bronchial asthma were randomly allocated to the unloaded respiratory muscle training (Placebo training group; n = 17), inspiratory muscle training alone (inspiratory muscle training group; n = 17), or combined inspiratory and expiratory muscle training in the same cycle (combined training group; n = 17). All groups were assessed for respiratory muscle strength, pulmonary functions, and asthma symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fifty-one children with bronchial asthma were recruited from King Khalid Hospital, Al-Kharj, Saudi Arabia. The study included children who had a confirmed diagnosis of bronchial asthma according to the Global Initiative for Asthma guidelines, aged 12-18 years, identified as being stable cases, had a baseline percent-predicted value of the peak expiratory flow rate of 60-80%, sustained stale doses of medications in the past three months. Children who had unstable asthma or exacerbated asthma symptoms, history of thoracic surgery, or cardiopulmonary comorbidities were excluded.

Outcome measures

1. Respiratory muscle strength: assessed by measuring the maximal inspiratory and expiratory pressure using an electronic respiratory pressure meter.
2. Pulmonary function: The forced vital capacity (FVC), forced expiratory volume in the first second of expiration (FEV1), and FEV1/FVC ratio, were measured in a pulmonary function test through a spirometry analyzer.
3. Control of asthma symptoms: Asthma symptoms were assessed using a translated version of the asthma control test.

All groups received the conventional respiratory re-training program, three times a week, for 12 weeks in succession. The placebo group additionally received unloaded respiratory muscle training, the inspiratory muscle training group received respiratory muscle training alone, and the combined group received combined inspiratory and expiratory muscle training in the same cycle. Interventions were conducted by a licensed physical therapist who had experience of more than 10 years of respiratory training.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchial Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

A randomized, placebo-controlled, assessor-blinded clinical trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The outcome assessor was blinded to the treatment allocation

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo group

This group received a conventional respiratory retraining program plus unloaded (placebo) respiratory muscle training

Group Type PLACEBO_COMPARATOR

Placebo respiratory muscle training

Intervention Type OTHER

Unloaded respiratory muscle training plus conventional respiratory exercises

Inspiratory muscle training group

This group received a conventional respiratory retraining program plus inspiratory muscle training only

Group Type ACTIVE_COMPARATOR

Inspiratory muscle training

Intervention Type OTHER

Inspiratory muscle training plus conventional respiratory exercises

Combined training group

This group received a conventional respiratory retraining program plus inspiratory and expiratory muscle training in the same respiratory cycle.

Group Type EXPERIMENTAL

Combined inspiratory and expiratory muscle training

Intervention Type OTHER

Combined inspiratory and expiratory muscle training in the same respiratory cycle plus conventional respiratory exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo respiratory muscle training

Unloaded respiratory muscle training plus conventional respiratory exercises

Intervention Type OTHER

Inspiratory muscle training

Inspiratory muscle training plus conventional respiratory exercises

Intervention Type OTHER

Combined inspiratory and expiratory muscle training

Combined inspiratory and expiratory muscle training in the same respiratory cycle plus conventional respiratory exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed diagnosis of asthma according to Global Initiative of Asthma guidelines.
* Age between 12 and 18 years.
* Clinically stable asthma.
* Stable doses of medications in the last three months
* A percent-predicted value of the peak expiratory flow rate of 60-80%
* No activity limitation due to asthma

Exclusion Criteria

* Unstable asthma
* Exacerbation of asthma symptoms
* History of thoracic surgery
* Cognitive/behavioral problems
* Cardiopulmonary co-morbidities
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ragab Kamal Elnaggar

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ragab K Elnaggar, PhD

Role: PRINCIPAL_INVESTIGATOR

Prince Sattam Bin Abdulaziz University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ragab K. Elnaggar

Al Kharj, Riyadh Region, Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RHPT/0020/0061

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breathing Exercises for Asthma
NCT02151422 COMPLETED NA
Exercise Training in Asthma
NCT00820716 TERMINATED NA